全文获取类型
收费全文 | 2624篇 |
免费 | 271篇 |
国内免费 | 17篇 |
专业分类
耳鼻咽喉 | 28篇 |
儿科学 | 92篇 |
妇产科学 | 43篇 |
基础医学 | 438篇 |
口腔科学 | 165篇 |
临床医学 | 302篇 |
内科学 | 551篇 |
皮肤病学 | 58篇 |
神经病学 | 215篇 |
特种医学 | 147篇 |
外科学 | 317篇 |
综合类 | 22篇 |
一般理论 | 3篇 |
预防医学 | 194篇 |
眼科学 | 51篇 |
药学 | 162篇 |
中国医学 | 3篇 |
肿瘤学 | 121篇 |
出版年
2023年 | 37篇 |
2022年 | 15篇 |
2021年 | 42篇 |
2020年 | 46篇 |
2019年 | 50篇 |
2018年 | 89篇 |
2017年 | 90篇 |
2016年 | 95篇 |
2015年 | 113篇 |
2014年 | 117篇 |
2013年 | 228篇 |
2012年 | 154篇 |
2011年 | 148篇 |
2010年 | 134篇 |
2009年 | 73篇 |
2008年 | 87篇 |
2007年 | 108篇 |
2006年 | 101篇 |
2005年 | 91篇 |
2004年 | 110篇 |
2003年 | 78篇 |
2002年 | 85篇 |
2001年 | 36篇 |
2000年 | 15篇 |
1999年 | 21篇 |
1998年 | 51篇 |
1997年 | 34篇 |
1996年 | 35篇 |
1995年 | 36篇 |
1994年 | 21篇 |
1993年 | 16篇 |
1992年 | 19篇 |
1991年 | 18篇 |
1990年 | 12篇 |
1989年 | 22篇 |
1988年 | 19篇 |
1987年 | 17篇 |
1986年 | 21篇 |
1985年 | 19篇 |
1984年 | 26篇 |
1982年 | 22篇 |
1981年 | 13篇 |
1980年 | 19篇 |
1979年 | 16篇 |
1978年 | 15篇 |
1977年 | 14篇 |
1955年 | 39篇 |
1954年 | 90篇 |
1949年 | 22篇 |
1948年 | 17篇 |
排序方式: 共有2912条查询结果,搜索用时 31 毫秒
91.
Walid KH Fakhoury 《Archives of Suicide Research》2013,17(4):363-371
Little information is available on the profile of suicidal mentally ill sufferers seeking help from helplines. In this article we describe the profile and experience with services of suicidal people calling SANELINE, a national mental health helpline in the UK. Analyses were conducted on 1,331 calls made during 1996-1997 by callers who resided in London. Sixty-one percent of all callers were female. Half of all callers were suffering from depression and 32% from psychosis. Psychotic sufferers were significantly more likely not to have been complying with treatment, to have wanted information about medication, and to have been dissatisfied with the local services. Suicidal psychotic sufferers were more likely than non-suicidal ones to have inquired about mental health laws or about state benefits. On the other hand, depressive sufferers were more likely to have wanted information about social support groups, and to have complained about the lack of services in their area of residence. The findings suggested the need to target male sufferers, to meet the information needs of suicidal people with psychosis or depression, and to increase awareness about available sources of help. 相似文献
92.
93.
94.
95.
96.
97.
T. ELM D. M. KARPF K. ØVLISEN H. PELZER M. EZBAN M. KJALKE M. TRANHOLM 《Haemophilia》2012,18(1):139-145
Summary. N8 is a new recombinant factor VIII (rFVIII) compound produced and formulated without human‐ or animal‐derived protein. The aims of the present studies were to evaluate the pharmacokinetics and pharmacodynamics properties of N8 and to compare with a commercially available rFVIII product (Advate®) in haemophilia A mice. The pharmacokinetics were evaluated after single i.v. administration of 80, 120 and 280 IU kg?1 of N8 and Advate® and measurements of FVIII blood concentrations as a function of time. The efficacy and dose response curves of N8 and Advate® (1–200 IU kg?1) were evaluated in a tail bleeding model. Furthermore, the effects in a newly developed haemophilia knee joint haemarthrosis model were investigated. No significant differences were found in the pharmacokinetic parameters between N8 and Advate®. The clearances were 11 ± 1 vs. 10 ± 2 mL h?1 kg?1 (P = 0.14) and the half‐lives 7.2 ± 0.9 vs. 7.7 ± 1.4 h (P = 0.31) after administration of N8 and Advate® respectively. Dose‐independent pharmacokinetics was shown, and comparable efficacy and potency were shown between N8 and Advate® in the tail bleeding model. Both compounds normalized the bleeding at the dose of 200 IU kg?1, and for blood loss ED50 values of 27 IU kg?1 (N8) and 28 IU/kg (Advate®) were found (P = 0.97). In the haemarthrosis model, treatment with N8 and Advate® at 200 IU kg?1 reduced the mean increase in the joint diameter significantly from 1.23 ± 0.19 to 0.32 ± 0.08 mm (P < 0.01) and 0.25 ± 0.08 mm (P < 0.001) respectively. Pharmacokinetics and pharmacodynamics of N8 and Advate® were comparable after i.v. administration to haemophilia A mice. 相似文献
98.
S?rensen B Benson GM Bladen M Classey S Keeling DM McLaughlin P Yee TT Makris M 《Haemophilia》2012,18(4):598-606
Treatment studies in haemophilia focus on joint bleeds; however, some 10-25% of bleeds occur in muscles. This review addresses management of muscle haematoma in severe haemophilia, defines gaps in the published evidence, and presents a combined clinician and physiotherapist perspective of treatment modalities. The following grade 2C recommendations were synthesized: (i) Sport and activity should be based on individual factor levels, bleeding history and physical characteristics, (ii) Musculoskeletal review aids the management of children and adults, (iii) 'Time to full recovery' should be realistic and based on known timelines from the healthy population, (iv) Diagnosis should be carried out by both a clinician and physiotherapist, (v) Severe muscle bleeds should be treated similarly to surgical patients: a 50% trough for 10-14 days followed by high-level prophylaxis, (vi) Protection, rest, ice, compression and elevation should be implemented in the acute stage, and (vii) Physiotherapy and rehabilitation should be divided into: control of haemorrhage (phase 1); restoration of Range of Movement (ROM) and strength (phase 2); functional rehabilitation and return to normal living (phase 3). Recommendations specifically for inhibitor patients include: (i) Minor to moderate bleeds should be managed by home-treatment within 1 h of bleed onset using either one injection of rFVIIa 270 μg kg(-1), or two to three injections of rFVIIa 90 μg kg(-1) (2-3 h intervals), or FEIBA 50-100 U kg(-1) (repeated at 12-hourly intervals, if necessary) and (ii) Severe muscle bleeds should be supervised by the treatment centre and include bypassing agents until clinical improvement is observed. 相似文献
99.
100.
A. K. Knudsen S. B. Harvey A. Mykletun S. Øverland 《Acta psychiatrica Scandinavica》2013,127(4):287-297
Objective: To examine and compare the prospective effect of the common mental disorders (CMD) anxiety and depression on duration and recurrence of sickness absence (SA), and to investigate whether the effect of CMD on SA is detectable over time. Method: Information from a large epidemiological health study (N = 13 436) was linked with official records of SA episodes lasting ≥16 days up to 6 years after participation. Common mental disorders were assessed with the Hospital Anxiety and Depression Scale (HADS). Associations were analysed with Cox regression and multinomial logistic regression models controlling for potential covariates. Results: Comorbid anxiety and depression, and anxiety only were significant risk factors for SA after adjusting for covariates, whilst depression only was not. Anxiety and depression were stronger predictors for longer duration of SA episodes compared with shorter duration and associated with more frequent recurrence of SA. There was a general trend toward the effect of CMD on SA becoming weaker over time; however, the effect of anxiety only on SA remained stable throughout the follow‐up. Conclusion: Common mental disorders are long‐lasting predictors of onset, duration and recurrence of SA. Anxiety appears to be a more important contributor to long‐term SA than previously described in the literature. 相似文献